Credit Suisse Ag Ascendis Pharma A/S Transaction History

Credit Suisse Ag

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$86.5 - $103.97 $11,418 - $13,724	132 Added 1.5%	8,932 $836,000
Q2 2023 Aug 11, 2023	BUY	$69.96 - $97.84 $265,848 - $371,792	3,800 Added 76.0%	8,800 $785,000
Q1 2023 May 10, 2023	BUY	$104.9 - $126.78 $232,982 - $281,578	2,221 Added 79.92%	5,000 $536,000
Q4 2022 Feb 13, 2023	BUY	$99.42 - $131.97 $276,288 - $366,744	2,779 New	2,779 $339,000
Q2 2022 Aug 12, 2022	SELL	$78.08 - $117.61 $460,672 - $693,899	-5,900 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$102.18 - $135.75 $602,862 - $800,925	5,900 New	5,900 $692,000
Q4 2021 Feb 14, 2022	SELL	$127.1 - $169.66 $179,211 - $239,220	-1,410 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$112.67 - $176.92 $327,193 - $513,775	-2,904 Reduced 67.32%	1,410 $225,000
Q2 2021 Aug 16, 2021	BUY	$121.62 - $145.29 $121 - $145	1 Added 0.02%	4,314 $568,000
Q1 2021 May 14, 2021	BUY	$124.92 - $173.33 $374 - $519	3 Added 0.07%	4,313 $556,000
Q4 2020 Feb 12, 2021	SELL	$151.2 - $182.76 $13,456 - $16,265	-89 Reduced 2.02%	4,310 $719,000
Q3 2020 Nov 13, 2020	SELL	$134.29 - $154.32 $482,235 - $554,163	-3,591 Reduced 44.94%	4,399 $680,000
Q2 2020 Aug 12, 2020	BUY	$110.87 - $156.01 $124,285 - $174,887	1,121 Added 16.32%	7,990 $1.18 Million
Q1 2020 May 13, 2020	SELL	$97.01 - $145.11 $837,681 - $1.25 Million	-8,635 Reduced 55.7%	6,869 $774,000
Q4 2019 Feb 12, 2020	BUY	$91.45 - $139.12 $1.04 Million - $1.58 Million	11,327 Added 271.18%	15,504 $2.16 Million
Q3 2019 Nov 12, 2019	BUY	$95.8 - $118.9 $400,156 - $496,645	4,177 New	4,177 $402,000

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.